Behavior of HIV-AIDS at 13 de Marzo policlinic. 2000-2009.
Keywords:
HIV, ACQUIRED IMMUNODEFICIENCY SYNDROME/epidemiologyAbstract
It was performed a descriptive, prospective and longitudinal research to determine the behavior of HIV-AIDS at 13 de Marzo Policlinic in Bayamo, during the period January 1rst, 2000 to May 31, 2009. The universe as made by 65020 persons who had developed the HIV test and the sample was made by 41 patients infested by the Human inmunodeficiency virus. They presented positivity in the test that was applied to them in order to know the variables like sex, age, occupation, way of tranmission, sexual behavior and complications. In the research the greatest amount of cases were seropositives, in the year 2006 there were diagnosed the biggest amount of seropositives. Male patients prevailed. The most affected group of age was from 20-35 years followed by the group from 36 years and older. Most of the patients had jobs, the way of transmission was by sexual intercourse and homosexuals were mostly affected. Candidiasis and recurrent skin lesions were the most frequent complications.
Statistical methods were applied and through this information the data was gathered, using total values and percentages. Tables were made and the results were analized and discussed, reaching final conclusions.
Downloads
References
1. Ziegler JL, Beckstad JA, Volberding PA. Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenophathy and acquired immunodeficiency syndrome. New Engl J Med. 2005: 311(9): 565-70
2. Soler M, Sanjose S, Ribera JM, Dalmaso L, Casanova J. Epidemiology of AIDS associated malignances. AIDS Rev 2001; 5: 44-55.
3. Saag MS, Holodnly M, Kuritzkes DR. HIV viral load markers in clinical practice: recommendations of and International IDS Sosiety –USA Expert Panel. Nat Med. 2004; 2:625-9.
4. Miralles P, Rubio C, berenguer J, Ribera JM, Calvo F. Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el VIH. Med Clin (Barc) 2002; 118(6): 225-36.
5. Goudert JJ, Cote TR, Virgo P, Scoppa SM, Kigma DW, Gail MH. Spectrum of AIDS- associated malignant disorders. Lancet 2003; 351: 1833-9.
6. Knowles DM, Chamulak GA, Subar M. Lymphoid neoplasia associated with the acquired immunodeficiency symdrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 2006; 108(5): 744-53.
7. Kapland LD, Abrams DI, Feigal E. AIDS’s associated non Hodgkin lymphoma in San Francisco. JAMA 2002; 261(5): 719-24.
8. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adult. J Nati Cancer Inst 2004; 92(22): 1823-30.
9. Gerard L, Galicier L, Boulanger E. Improved survival in HIV- related Hodgkins lymphoma since the introduction of highly active antiretroviral therapy. AIDS 2003; 17(1): 81-7.
10. Hoffmann C, Wolf E, Fatkenheuer G. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS- related lymphoma. AIDS 2003; 17(10): 1521-9.
11. Besson C, Goubear A, Gabarre J. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98: 2339-44.
12. Herida M, Mary-Krause M. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral theraphy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21: 3447-53.
13. Mocroft A, Katiama C, Johnson AM, Pradier C, Antunes F. AIDS across Europe, 1994-1998: EuroSIDA study. Lancet 2000; 356: 291-6.
14. CASCADE Collaboration. Change in the uptake of antiretroviral theraphy and survival in persnons with know duration of HIV infection in Europe. HIV Medicine 2000; 1: 224-31.
15. Collaborative Group on AIDS Incubation and HIV survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral theraphy: a collaborative re-analysis. Lancet 2000; 355: 1131-7.
16. Stebbing J, Gazzard B, mandalia S. Antiretroviral treatment and immune parameters in the prevention of systemic AIDS-related non Hodgkins lymphoma. J Clin Oncol 2004; 22(11): 2177-83.
17. Cote TR, Biggar RJ, Rosenberg PS. Non-Hodgkins lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997; 73: 645-50.
18. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumors. Phatology and genetics tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2005.
19. Simonelli C, Spina M, Cinelli R. Clinical features and outcome of primary efusión lymphoma in HIV- infected patients: a single-institution study. J Clin Oncol 2003; 21: 3948-54.
20. Lester D, Thompson LD, Fisher SI, Chu W, Nelson A. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Phatol 2004; 121(5): 727-38.
21. Spina M, Vacher E, Nasti G. Human inmunodeficiency virus associated Hodgkins disease. Semin Oncol 2005; 27(4):480-8.
22. Vaccher E, Tirelli U, Spina M, Talamini R, Errante D, Simnelli C. Age and serum lactate dishydrogenase level are independent prognostic factors in human immunodeficiency virus related non Hodgkins lymphoma: a single institute study of 96 patients. J Clin Oncol 2004; 14: 2217-23.
23. Re A, Casari S, Cattaneo C. Hodgkin disease developing in patients infected by human immunodeficiency virus-related non Hodgkin lymphoma. Cancer 2001; 92(11): 2739-45.
24. Levine AM. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol 2000; 27(4): 442-53.
Downloads
Published
How to Cite
Issue
Section
License
Avisos de derechos de autor propuestos por Creative Commons
1. Política propuesta para revistas que ofrecen acceso abierto
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).